Last reviewed · How we verify

[68Ga]Ga-NODAGA-SNA014

SmartNuclide Biopharma · Phase 1 active Small molecule

[68Ga]Ga-NODAGA-SNA014 is a Small molecule drug developed by SmartNuclide Biopharma. It is currently in Phase 1 development.

At a glance

Generic name[68Ga]Ga-NODAGA-SNA014
SponsorSmartNuclide Biopharma
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about [68Ga]Ga-NODAGA-SNA014

What is [68Ga]Ga-NODAGA-SNA014?

[68Ga]Ga-NODAGA-SNA014 is a Small molecule drug developed by SmartNuclide Biopharma.

Who makes [68Ga]Ga-NODAGA-SNA014?

[68Ga]Ga-NODAGA-SNA014 is developed by SmartNuclide Biopharma (see full SmartNuclide Biopharma pipeline at /company/smartnuclide-biopharma).

What development phase is [68Ga]Ga-NODAGA-SNA014 in?

[68Ga]Ga-NODAGA-SNA014 is in Phase 1.

Related